Biotechnology
Healthcare
Investing News
Market News
Technology
The Market Buzz
Arcturus Therapeutics Receives Approval from Health Sciences Authority to Proceed with Phase 2 Study of Vaccine Candidate
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) reported approval from the Singapore Health Sciences Authority to commence its Phase 2 clinical study of its vaccine candidate ARCT-021. The study will...